Chief Financial Officer

Vice President, Clinical Research and Regulatory Affairs

Arcellx resumed with a Buy at Stifel

Arcellx assumed with a Neutral at Cantor Fitzgerald

Arcellx Insider Sold Shares Worth $1,709,723, According to a Recent SEC Filing

Arcellx's Chief Medical Officer Sells Shares

Medical Science Liaison

Arcellx is a public, clinical-stage biotechnology company focused on developing innovative cell therapies for patients with cancer and other incurable diseases. The Medical Science Liaison (MSL) will act as a key scientific resource, establishing relationships with healthcare professionals and engaging in medical education to support Arcellx's transformative therapies.

Medical Science Liaison (New York / New Jersey)

Chief People Officer

Senior Medical Science Liaison

Sign up with Google

Sign in with Google